Decrease of serum levels of soluble CD23 during immunotherapy in patients with perennial allergic rhinitis

Annals of Otology, Rhinology and Laryngology

Volumn 108, Issue 2 I, 1999, Pages 193-200

  Tanaka, Ayaki ^a   Ohashi, Yoshihiro ^a   Nakai, Yoshiaki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Immunotherapy; Perennial allergic rhinitis; Soluble CD23; Specific IgE

Indexed keywords

CD3 ANTIGEN; IMMUNOGLOBULIN E;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DERMATOPHAGOIDES FARINAE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYMPTOMATOLOGY;

EID: 0032979354     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348949910800216     Document Type: Article

References (24)

1. Spiegelberg HL, O'Connor RD, Simon RA, Mathison DA. Lymphocytes with immunoglobulin E Fc receptors in patients with atopic disorders. J Clin Invest 1979;64:714-20.
2. Gordon J, Flores-Romo L, Cairns JA, et al. CD23 a multifunctional receptor/lymphokine? Immunol Today 1989:10:153-7.
3. Spiegelberg HL. The expression of IgE Fc receptors on lymphocytes of allergic patients. Int Rev Immunol 1987;2:63-71.
4. Suemura M, Kishimolo J. IgE class-specific regulatory factors and Fce receptors on lymphocytes. Int Rev Immunol 1987;2:27-42.
5. Watanabe N, Yanagihara Y, Joh K, Hamada A, Tomita Y, Kobayashi A. Fc-epsilon-receptor-bearing lymphocytes in patients with clonorchiasis. Int Arch Allergy Appl Immunol 1989; 89:103-7.
6. Nagai T, Adachi M, Noro N, Yodoi J, Uchida H. T and B lymphocytes with immunoglobulin E Fc receptors (FceR) in patients with nonallergic hyperimmunoglobulinemia E: demonstration using a monoclonal antibody against FceR-associated antigen. Clin Immunol Immunopathol 1985:35:261-75.
7. Conrad DH. The low affinity receptor for IgE. Annu Rev Immunol 1990;8:623-45.
8. Letellier M, Nakajima T, Pulido-Cejudo G, Hofstetter H, Dellespesse G. Mechanism of formation of human IgE-binding factors (soluble CD23). III. Evidence for a receptor (FceRII)-associated proteolytic activity. J Exp Med 1990;172:693-700.
9. Sarfati M, Rector E, Wong K, Rubio-Truijillo M, Sehon AH, Delespesse G. In vitro synthesis of IgE by human lymphocytes. II. Enhancement of the spontaneous IgE synthesis by IgE-binding factors secreted by RPMI 8866 lymphoblastoid B cells. Immunology 1984;53:197-205.
10. Sarfati M, Delespesse G. Possible role of human lymphocyte receptor for IgE (CD23) or its soluble fragments in the in vitro synthesis of human IgE. J Immunol 1988;141:2195-9.
11. Pene J, Rousset F, Briere F, et al. Interleukin 5 enhances interleukin 4-induced IgE production by normal human B cells: the role of soluble CD23 antigen. Eur J Immunol 1988;18:929-35.
12. Pene J, Chretien I, Rousset F, Briere F, Bonnefoy JY, de Vries JE. Modulation of IL-4-induced human IgE production in vitro by IFN-γ and IL-5: the role of soluble CD23 (sCD23). J Cell Biochem 1989;39:253-64.
13. Saxon A, Ke Z, Bahati L, Stevens RH. Soluble CD23 containing B cell supernatants induce IgE from peripheral blood B-lymphocytcs and costimulate with interleukin-4 in induction of IgE. J Allergy Clin Immunol 1990;86:333-44.
14. Matsumoto T, Miike T, Yamaguchi K, Murakami M, Kawabe T, Yodoi J. Serum levels of soluble IL-2 receptor. IL-4 and IgE-binding factors in childhood allergic diseases. Clin Exp Immunol 1991;85:282-92.
15. Yanagihara Y, Sarfati M, Marsh D, Nutman T, Delespesse G. Serum levels of IgE-binding factor (soluble CD23) in diseases associated with elevated IgE. Clin Exp Allergy 1990;20:395-401.
16. Reddy MM, Weissman AM, Mazza DS, Meriney DK, Johns M, Grieco MH. Circulating elevated levels of soluble CD23, interleukin-4, and CD20+CD23+ lymphocytes in atopic subjects with elevated serum IgE concentrations. Ann Allergy 1992;69:131-4.
17. Kim KM, Nanbu M, Iwai Y, et al. Soluble low affinity Fc receptors for IgE in the serum of allergic and nonallergic children. Pediatr Res 1989;26:49-53.
18. Ohashi Y, Nakai Y, Okamoto H. et al. Serum level of interleukin-4 in patients with perennial allergic rhinitis during allergen-specific immunotherapy. Scand J Immunol 1996;43: 680-6.
19. Ohashi Y, Nakai Y, Okamoto H, et al. Significant correlation between symptom score and IgG4 antibody titer following long-term immunotherapy for perennial allergic rhinitis. Ann Otol Rhinol Laryngol 1997;106:483-9.
20. 41st World Medical Assembly. Declaration of Helsinki: recommendations guideline for physicians in biomedical research involving human subjects. Bull Pan Am Health Organ 1990;24:606-9.
21. Ohashi Y, Nakai Y, Kakinoki Y, et al. Immunotherapy affects the seasonal increase in specific IgE and interleukin-4 in serum of patients with seasonal allergic rhinitis. Scand J Immunol 1997;46:67-77.
22. Yanagihara Y, Kiniwa M, Kajiwara K, Shida T. Establishment of a sensitive radioimmunoassay for the detection of human IgE-binding factor (soluble CD23). Int Arch Allergy Immunol 1992;98:189-99.
23. Ohashi Y, Nakai Y, Ohno Y, et al. Natural course of serum specific IgE and IgG4 for a span of eight years in untreated patients with perennial allergic rhinitis. Laryngoscope 1997;107: 382-5.
24. Forman SO, Reddy MM, Mazza DS, Meriney DK, Grieco MH. Effect of immunotherapy on sCD23 levels in patients allergic to Hymenoptera venom. Ann Allergy Asthma Immunol 1996;77:282-4.